Standout Papers

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous... 2017 2026 2020 2023 332
  1. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer (2017)
    Bailiang Li, Yi Cui et al. JAMA Oncology

Immediate Impact

3 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Cross-priming in cancer immunology and immunotherapy
2025 Standout
Artificial intelligence in drug development
2025 Standout
2 intermediate papers

Works of Bailiang Li being referenced

Single-Cell Spatial Analysis of Tumor and Immune Microenvironment on Whole-Slide Image Reveals Hepatocellular Carcinoma Subtypes
2020
Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit
2020

Author Peers

Author Last Decade Papers Cites
Bailiang Li 392 399 335 22 949
Robin Edwards 472 209 486 24 1.0k
Neal Poulin 340 434 463 29 1.1k
Maud H. W. Starmans 213 300 493 26 1.1k
Craig Barker 789 431 131 36 1.0k
Regan Fulton 638 249 245 30 1.1k
Rachel L. Stewart 329 144 372 29 888
Lian Xu 440 310 464 39 1.1k
Glenn Francis 518 281 447 39 1.1k
Marc A. Attiyeh 764 275 349 30 1.1k
Dijana Djureinovic 400 215 323 24 836

All Works

Loading papers...

Rankless by CCL
2026